CU20100083A7 - Tolerogenos adyuvados como vacuna de malaria - Google Patents
Tolerogenos adyuvados como vacuna de malariaInfo
- Publication number
- CU20100083A7 CU20100083A7 CU20100083A CU20100083A CU20100083A7 CU 20100083 A7 CU20100083 A7 CU 20100083A7 CU 20100083 A CU20100083 A CU 20100083A CU 20100083 A CU20100083 A CU 20100083A CU 20100083 A7 CU20100083 A7 CU 20100083A7
- Authority
- CU
- Cuba
- Prior art keywords
- tolerogens
- malaria
- vaccine
- adjused
- induce
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invención se relaciona con el campo de las composiciones vacunales para el tratamiento efectivo o preventivo de infecciones de transmisión vertical, particularmente la Malaria y preferiblemente la humana causada por Plasmodium falciparum. El objetivo técnico que se persigue es usar los tolerógenos transferidos tempranamente de la madre al feto/recién nacido y formularlos con potentes adyuvantes inductores de respuestas Th1 y T citotóxica para su uso en vacunas profilácticas o terapéuticas contra las infecciones de transmisión vertical y particularmente la Malaria. El empleo de estas formulaciones por vía parenteral o mucosal o ambas a la vez en edades tempranas, revierte la tolerancia inducida por la transferencia de tolerógenos y con ello inducir respuestas protectivas.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20100083A CU20100083A7 (es) | 2010-05-05 | 2010-05-05 | Tolerogenos adyuvados como vacuna de malaria |
ARP110101532A AR081008A1 (es) | 2010-05-05 | 2011-05-04 | Tolerogenos adyuvados como vacuna de malaria |
RU2012151576/10A RU2012151576A (ru) | 2010-05-05 | 2011-05-05 | Адъювантированные толерогены в качестве вакцины от малярии |
EP11777295.4A EP2548572A4 (en) | 2010-05-05 | 2011-05-05 | TOLEROGENES ADJUVATED AS VACCINES AGAINST MALARIA |
PCT/CU2011/000002 WO2011137876A2 (es) | 2010-05-05 | 2011-05-05 | Tolerogenos adyuvados como vacuna de malaria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20100083A CU20100083A7 (es) | 2010-05-05 | 2010-05-05 | Tolerogenos adyuvados como vacuna de malaria |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20100083A7 true CU20100083A7 (es) | 2012-06-21 |
Family
ID=44904160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20100083A CU20100083A7 (es) | 2010-05-05 | 2010-05-05 | Tolerogenos adyuvados como vacuna de malaria |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2548572A4 (es) |
AR (1) | AR081008A1 (es) |
CU (1) | CU20100083A7 (es) |
RU (1) | RU2012151576A (es) |
WO (1) | WO2011137876A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200141935A1 (en) | 2017-06-23 | 2020-05-07 | Barcelona Institute For Global Health | System, method, apparatus and diagnostic test for pregnancy |
CN112956668A (zh) * | 2021-03-11 | 2021-06-15 | 浙江省农业科学院 | 一种超声辅助生物酶法制备破壁蜂花粉的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01125328A (ja) | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
CU22983A1 (es) | 2002-05-08 | 2004-09-09 | Inst Finlay | Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas |
CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
US20070122417A1 (en) * | 2003-09-30 | 2007-05-31 | Patrick Holt | Immunotherapy method |
CU23420A1 (es) | 2003-12-30 | 2009-09-08 | Univ De Cambridge | Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes |
US8026354B2 (en) * | 2005-11-23 | 2011-09-27 | Institut Pasteur | Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
CU20080215A7 (es) | 2008-11-19 | 2012-06-21 | Inst Finlay | Vacunas unitemporales |
-
2010
- 2010-05-05 CU CU20100083A patent/CU20100083A7/es unknown
-
2011
- 2011-05-04 AR ARP110101532A patent/AR081008A1/es unknown
- 2011-05-05 WO PCT/CU2011/000002 patent/WO2011137876A2/es active Application Filing
- 2011-05-05 RU RU2012151576/10A patent/RU2012151576A/ru not_active Application Discontinuation
- 2011-05-05 EP EP11777295.4A patent/EP2548572A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2011137876A3 (es) | 2012-01-05 |
RU2012151576A (ru) | 2014-06-10 |
WO2011137876A2 (es) | 2011-11-10 |
EP2548572A4 (en) | 2013-12-11 |
EP2548572A2 (en) | 2013-01-23 |
AR081008A1 (es) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
MD4754B1 (ro) | Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică | |
PH12015500401B1 (en) | Pyrazolopyramidine compounds | |
PH12014501041B1 (en) | Vaccines directed against human enteroviruses | |
PH12015501100A1 (en) | Novel compounds | |
CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
BR112015008417A8 (pt) | composição imunogênica, vacina, e, uso de uma composição imunogênica | |
MX2015007688A (es) | Composicion de vacunas para uso en poblaciones inmunocomprometidas. | |
UY32208A (es) | Uso de antigeno de mycoplasma bovis | |
BR112016002354A2 (pt) | composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit | |
MX2013003245A (es) | Vacuna contra virus de diarrea viral de bovinos. | |
CU20100083A7 (es) | Tolerogenos adyuvados como vacuna de malaria | |
TN2012000217A1 (en) | The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease | |
IN2014DN08927A (es) | ||
CO6390020A2 (es) | Icam 1 soluble como biomarcador para predicción de respuesta terapéutica | |
MX368601B (es) | Composicion inmunogenica contra la aeromonas hydrophila. | |
EA201591803A1 (ru) | Разовые высокие дозы mva индуцируют защитный иммунный ответ у новорожденных и младенцев | |
HK1170183A1 (zh) | 腸球菌病原體的新的抗原及其用作疫苗組分用於治療和/或預防的用途 | |
CR20110469A (es) | Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio | |
MY176015A (en) | Immunogenic composition against aeromonas hydrophila | |
AR074754A1 (es) | Derivados de purina-8-ona | |
UY32356A (es) | Compuestos inductores del interferón humano y sus usos | |
CU20110123A7 (es) | Cocleato con solo mamp |